From: Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
 | Weighted Event Rate | Relative Risk Reduction | Number Needed to Treat | |
---|---|---|---|---|
Predicted Risk* | Control | Intervention | (95% CI) | Â |
< 5% | 15/428 (3.5%) | 17/431 (3.9%) | -13% (-122%, 43%))** | -250** |
5%-15% | 66/581 (11.4%) | 48/580 (8.3%) | 27% (-4%, 49%) | 32 |
> 15% | 66/310 (21.3%) | 38/307 (12.4%) | 42% (16%, 60%) | 11 |
Overall | 147/1319 (11.1%) | 103/1318 (7.8%) | 30% (11%, 45%) | 30 |